Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Garden House is a pharmaceutical and nutraceutical company that specializes in the development and marketing of natural-origin health products. The company is most famous for its brand Prunelax (known as Ciruelax in Spanish-speaking regions), which is one of the world's top-selling natural laxatives derived from senna fruit and leaves. Garden House's portfolio includes a wide range of over-the-counter (OTC) supplements targeting digestive health, weight control, and nutritional wellness. Following its acquisition by Laboratorios Siegfried (part of the Roemmers Group) in 2012, the brand has maintained a strong presence across Latin America and international markets, including the United States. The company focuses on bridging the gap between traditional herbal medicine and modern pharmaceutical standards through rigorous quality control and standardized natural extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Garden House.